Eugene Williams

CIK: 0001927626

Transaction Breakdown

Open Market Buys (P)5 (55.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMN

ProMIS Neurosciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

PMN
ProMIS Neurosciences Inc.
Oct 30, 2026
Purchase(P)
Direct
1.3K shares at avg. $3.99$5K
PMN
ProMIS Neurosciences Inc.
May 20, 2026
Award(A)
Option (right to buy)
Direct
11K shares-
PMN
ProMIS Neurosciences Inc.
May 20, 2026
Award(A)
Option (right to buy)
Direct
5.5K shares-
PMN
ProMIS Neurosciences Inc.
Mar 5, 2026
Purchase(P)
Direct
2K shares at avg. $24.40$49K
PMN
ProMIS Neurosciences Inc.
Mar 4, 2026
Purchase(P)
Direct
2K shares at avg. $24.00$48K
PMN
ProMIS Neurosciences Inc.
Mar 3, 2026
Purchase(P)
Direct
1K shares at avg. $21.89$22K
PMN
ProMIS Neurosciences Inc.
Mar 2, 2026
Purchase(P)
Direct
1K shares at avg. $22.53$23K
PMN
ProMIS Neurosciences Inc.
Jun 12, 2025
Award(A)
Option (right to buy)
Direct
20K shares-
PMN
ProMIS Neurosciences Inc.
Oct 3, 2024
Award(A)
Option (right to buy)
Direct
40K shares-

		Type	Shares	Price		Ownership
Oct 30, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	1,316	$3.99	$5,251	Direct
May 20, 2026	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	11,000	-	-	Direct
May 20, 2026	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	5,500	-	-	Direct
Mar 5, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	2,000	$24.40	$48,800	Direct
Mar 4, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	2,000	$24.00	$48,000	Direct
Mar 3, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	1,000	$21.89	$21,890	Direct
Mar 2, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	1,000	$22.53	$22,530	Direct
Jun 12, 2025	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	20,000	-	-	Direct
Oct 3, 2024	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	40,000	-	-	Direct

1-9 of 9 transactions

About Williams Eugene

Williams Eugene (SEC CIK 0001927626) files insider reports with the SEC as Director of ProMIS Neurosciences Inc. (PMN).

Signal8 holds 6 ownership filings by Williams Eugene, all Form 4s, filed between Oct 7, 2024 and Nov 3, 2026. Those filings report 9 transactions, from Oct 3, 2024 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Williams Eugene's filings is in TORONTO.

Recent filings by Williams Eugene

Oct 30, 2026: Open-market purchase of PMN shares (Form 4, code P).
May 20, 2026: Grants or awards of PMN derivative securities (2 lines, Form 4, code A).
Mar 5, 2026: Open-market purchase of PMN shares (Form 4, code P).
Mar 4, 2026: Open-market purchase of PMN shares (Form 4, code P).
Mar 3, 2026: Open-market purchase of PMN shares (Form 4, code P).

Other insiders filing for ProMIS Neurosciences Inc. (PMN)

Cashman Neil, Chief Scientific Officer
Rubino Ivana, Chief Commercial Officer
Kaplan Johanne, Chief Development Officer
WYMAN WILLIAM W, Director
Warma Neil K, Chief Executive Officer
Shafmaster Madge K., Director

How to read Form 4 transaction codes